Nuvectis Pharma
NVCT · NASDAQ
$20.59+$1.65 (+8.71%)TodayMarket closed ·
Prev close $18.94
Who owns NVCT
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 54.5% of NVCT’s shares.
- Bentsur (Ron)11.7%
- Mosseri Marlio (Charles)9.9%
- Poradosu (Enrique)5.7%
- Shemesh (Shay)5.7%
- Next 6 largest institutions21.4%
- All other shareholders45.5%
| Holder | Shares | % of shares |
|---|---|---|
| Bentsur (Ron) | 3.69M | 11.70% |
| Mosseri Marlio (Charles) | 3.14M | 9.95% |
| Poradosu (Enrique) | 1.81M | 5.73% |
| Shemesh (Shay) | 1.79M | 5.69% |
| Soleus Capital Management, L.P. | 1.65M | 5.23% |
| Tang Capital Management, LLC | 1.55M | 4.92% |
| Perceptive Advisors LLC | 1.00M | 3.17% |
| BlackRock Institutional Trust Company, N.A. | 906.80K | 2.88% |
| Vanguard Capital Management, LLC | 872.48K | 2.77% |
| Iridian Asset Management LLC | 777.08K | 2.46% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Vanguard Total Stock Market Index Fund | 650.49K | 2.06% |
| iShares Russell 2000 ETF | 435.48K | 1.38% |
| Vanguard Extended Market Index Fund | 201.56K | 0.64% |
| Fidelity Small Cap Index Fund | 185.54K | 0.59% |
| iShares Russell 2000 Growth ETF | 161.77K | 0.51% |
Insider trades
Form 4 filings by officers, directors and large holders
Over the last 6 months, insiders bought $1.17M (2 trades) of NVCT on the open market, with no sales.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Carson Michael J. | Award | 30.00K | — |
| Mosseri Marlio Charles | Buy | 50.00K | $916.00K |
| BENTSUR RON | Buy | 12.50K | $250.00K |
| Sanchez Juan | Award | 35.00K | — |
| Kaplan Matthew L. | Award | 35.00K | — |
| Hoberman Kenneth | Award | 35.00K | — |
| Oliviero James F III | Award | 35.00K | — |
Short interest
Settled Sep 30, 2026
- Shares short
- 2.52M
- Days to cover
- 10.34
- % of shares outstanding
- 8.00%
- Average daily volume
- 243.83K
- Change since last report
- +6.8%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.